NDA 006823 · Casper Pharma LLC
Aquasol A
Vitamin A Palmitate · Injection
Last checked: Nov 20, 2026Latest source record: Sep 18, 2015 (newest FDA action)Source: Drugs@FDA, openFDA, CMS, ClinicalTrials.gov, PubMedMethods & limitations
First approved
1949
May 18, 1949
Approved uses
1
Original approval plus efficacy supplements
Registered trials
325
72 Phase 3, 19 recruiting
FAERS reports
0
0 serious, 0 with death reported
AI brief across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, FAERS and PubMed data on this page, plus web searches for pricing, exclusivity and pending FDA decisions.
What it is approved for
From the label in effect Mar 3, 2026.
INDICATIONS Retinyl palmitate injection is effective for the treatment of vitamin A deficiency. The parenteral administration is indicated when the oral administration is not feasible as in anorexia, nausea, vomiting, pre- and postoperative conditions, or it is not available as in the “Malabsorption Syndrome” with accompanying steatorrhea. Pediatric Use: Vitamin A treatment for deficiency states has been recognized as an especially effective and important therapy in the pediatric population. Vitamin A supplementation for deficiency states in this population has been addressed by the Committee on Clinical Practice Issues of the American Society for Clinical Nutrition, by the American Society for Parenteral and Enteral Nutrition, and by the World Health Organization.
Approval history
Original approval and efficacy supplements (new uses, populations or doses), newest first, with FDA's letters and labels.
- May 18, 1949 Original approval
1 products under this application
- AQUASOL A · VITAMIN A PALMITATE EQ 50,000 UNITS BASE/ML · INJECTABLE, INJECTION · Prescription
Clinical trials
Interventional ClinicalTrials.gov studies with "Vitamin A Palmitate" as an intervention, any sponsor and status, largest first.
- Deworming and Enhanced Vitamin A Every 6 Month in Rural Indian Children Aged 1-6Pivotal-lookingCompleted
University of OxfordAcademic, hospital or other
NCT00222547 · 720,000 participants · Start Jan 1999
Drug: Vitamin A; Albendazole · For: Village Children
Sites: Lucknow, India
- Infant Mortality Reduction by the Mass Administration of AzithromycinPivotal-lookingActive, not recruiting
University of California, San FranciscoAcademic, hospital or other
NCT04716712 · 694,400 participants (planned) · Start Oct 4, 2021 · Primary completion Jan 30, 2025
Drug: Azithromycin; Placebo · For: Child Mortality
Sites: San Francisco, California; Nouna, Burkina Faso; Ouagadougou, Burkina Faso
- Efficacy of Newborn Vitamin A Supplementation Versus Placebo in Improving Child Survival (NeoVitA Trial)Pivotal-lookingCompleted
Society for Applied StudiesAcademic, hospital or other
NCT01138449 · 44,984 participants · Start Jun 2010 · Primary completion Jun 2013
Drug: Vitamin A · For: Neonatal Vitamin A Supplementation
Sites: New Delhi, India
- Single-dose Postpartum Vitamin A Supplementation of Mothers and NeonatesPivotal-lookingCompleted
Johns Hopkins Bloomberg School of Public HealthAcademic, hospital or other
NCT00198718 · 28,220 participants · Start Nov 1997 · Primary completion May 2001
Drug: Vitamin A (retinyl palmitate) · For: Vitamin A Deficiency; HIV
- Carotene and Retinol Efficacy TrialPivotal-lookingCompleted
Fred Hutchinson Cancer CenterAcademic, hospital or other
NCT00712647 · 18,314 participants · Start May 1985 · Primary completion Dec 2004
Drug: Beta Carotene and Retinol · For: Lung Cancer
- Vitamin A Supplementation in Newborns StudyPivotal-lookingCompleted
Johns Hopkins Bloomberg School of Public HealthAcademic, hospital or other
NCT00114868 · 14,035 participants · Start Jun 1998 · Primary completion Apr 2001
Drug: Vitamin A · For: Infant, Newborn
Sites: Madurai, India
- Different Doses of Vitamin A Supplementation and Male and Female Morbidity and MortalityPivotal-lookingCompleted
Bandim Health ProjectAcademic, hospital or other
NCT00168636 · 11,000 participants · Start Nov 2004 · Primary completion Nov 2013
Drug: Vitamin A · For: Mortality; Morbidity
Sites: Bissau, Guinea-Bissau
- Investigating the Potential Role of Aerosolized Retinoic Acid, a Potent Vitamin A Metabolite for Treating COVID-19 Anosmia and Retinoic Acid Insufficiency .A Novel Approach for Regaining Sense of Smell.Pivotal-lookingStatus unknown
Kafrelsheikh UniversityAcademic, hospital or other
NCT05002530 · 10,000 participants (planned) · Start Nov 2021 · Primary completion Dec 2021
Drug: Aerosolized 13 cis retinoic acid plus Vitamin D; Aerosolized All trans retinoic acid plus Vitamin D · For: Post COVID-19 Anosmia (Loss of Smell)
Sites: Foshan, China; Kafr ash Shaykh, Egypt; Riyadh, Saudi Arabia
Most reported adverse reactions
FAERS reports naming this application or brand. Unverified reports, not rates; a report can name several drugs.
No FAERS reports name this application.
FAERS reports by year
By the date FDA received the report.
No reports.
Recalls
0 FDA enforcement reports for this application.
No recalls on record for this application.
Shortages
FDA's drug shortage list.
Not on FDA's shortage list.
Medicare spending
CMS Spending by Drug. Part D is pharmacy-dispensed; Part B is given in a clinic or hospital outpatient setting. Spending is before manufacturer rebates.
Not found under this brand name in Medicare's Part D or Part B Spending by Drug data. CMS lists some drugs under the generic name only.
Published evidence
PubMed clinical trials, meta-analyses and systematic reviews, most relevant first.
- Effectiveness of Fenugreek as an Adjuvant in the Management of Oral Potentially Malignant Disorders: A Randomized Controlled Trial.
Balasundaram N, Narayanan MA, Antony LSA, et al. · J Contemp Dent Pract 2024 · Randomized Controlled Trial
- A clinical study of topical treatment for thyroid-associated ophthalmopathy with dry eye syndrome.
Sun R, Yang M, Lin C, et al. · BMC Ophthalmol 2023 · Randomized Controlled Trial
- The protective effect of vitamin A palmitate eye gel on the ocular surface during general anaesthesia surgery: a randomized controlled trial.
Li S, Lei G, Liu Y, et al. · Int Ophthalmol 2024 · Randomized Controlled Trial
- Randomized controlled safety and efficacy trial of 2 vitamin A supplementation schedules in Tanzanian infants.
Idindili B, Masanja H, Urassa H, et al. · Am J Clin Nutr 2007 · Randomized Controlled Trial, Research Support, Non-U.S. Gov't
- ω-3 intake and visual acuity in patients with retinitis pigmentosa receiving vitamin A.
Berson EL, Rosner B, Sandberg MA, et al. · Arch Ophthalmol 2012 · Randomized Controlled Trial, Research Support, N.I.H., Extramural
- Clinical trial of lutein in patients with retinitis pigmentosa receiving vitamin A.
Berson EL, Rosner B, Sandberg MA, et al. · Arch Ophthalmol 2010 · Clinical Trial, Phase III, Randomized Controlled Trial
Sponsor: Casper Pharma LLC
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.